Clinical Feature and Predictive Model for Transplanted Patients with Functional High-Risk Multiple Myeloma

被引：0
|
作者：
Yu, Tongyong [1 ]
Li, Juan [1 ]
机构：
[1] Sun Yat Sen Univ, Affilated Hosp 1, Guangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4727 / 4727
页数：1
相关论文
共 50 条
  • [1] Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram
    Li, Yanjuan
    Kuang, Lifen
    Huang, Beihui
    Liu, Junru
    Chen, Meilan
    Li, Xiaozhe
    Gu, Jingli
    Yu, Tongyong
    Li, Juan
    BIOMEDICINES, 2025, 13 (01)
  • [2] Genomic characterization of functional high-risk multiple myeloma patients
    Soekojo, Cinnie Yentia
    Chung, Tae-Hoon
    Furqan, Muhammad Shaheryar
    Chng, Wee Joo
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [3] Genomic characterization of functional high-risk multiple myeloma patients
    Cinnie Yentia Soekojo
    Tae-Hoon Chung
    Muhammad Shaheryar Furqan
    Wee Joo Chng
    Blood Cancer Journal, 12
  • [4] Identifying the Genomic Profile of Functional High-Risk Multiple Myeloma Patients
    Soekojo, Cinnie Yentia
    Chung, Tae-Hoon
    Furqan, Muhammad Shaheryar
    Chng, Wee-Joo
    BLOOD, 2020, 136
  • [5] A predictive model for conversion to psychosis in clinical high-risk patients
    Ciarleglio, Adam J.
    Brucatoz, Gary
    Masucci, Michael D.
    Altschuler, Rebecca
    Colibazzi, Tiziano
    Corcoran, Cheryl M.
    Crump, Francesca M.
    Horga, Guillermo
    Lehembre-Shiah, Eugenie
    Leong, Wei
    Schobel, Scott A.
    Wall, Melanie M.
    Yang, Lawrence H.
    Lieberman, Jeffrey A.
    Girgis, Ragy R.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (07) : 1128 - 1137
  • [6] High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy
    Rees, Matthew J.
    Kumar, Shaji
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1560 - 1575
  • [7] Crowdsourcing a High-Risk Classifier for Multiple Myeloma Patients
    Dervan, Andrew P.
    Mason, Michael
    Towfic, Fadi
    Amatangelo, Michael
    Auclair, Daniel
    Bassett, Douglas
    Dai, Hongyue
    Dalton, William S.
    Danziger, Samuel
    Flynt, Erin
    Goldschmidt, Hartmut
    Guinney, Justin
    Hose, Dirk
    Mavrommatis, Konstantimos
    Morgan, Gareth J.
    Munshi, Nikhil
    Ratushny, Alexander
    Rozelle, Dan
    Samur, Mehmet Kemal
    Schmitz, Frank
    Shain, Kenneth H.
    Trotter, Matthew
    Walker, Brian A.
    White, Brian S.
    Yu, Thomas
    Thakurta, Anjan
    BLOOD, 2017, 130
  • [8] Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)
    Kim, Kihyun
    Kim, Jin Seok
    Yoon, Sung-Soo
    Yoon, Dok Hyun
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Yim, Hyeon Woo
    Park, Misun
    Lee, Hojoon
    Min, Chang-Ki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) : 110 - 121
  • [9] Clinical Course of High-Risk Multiple Myeloma Patients in Korea: A Multicenter Retrospective Study
    Kim, Kihyun
    Kim, Jin Seok
    Yoon, Sung-Soo
    Yoon, Dok-Hyun
    Eom, HyeonSeok
    Lee, Je-Jung
    Yim, Hyeonwoo
    Park, Misun
    Lee, Hojoon
    Min, Chang Ki
    BLOOD, 2020, 136
  • [10] Analysis of Clinical Characteristics and High-Risk Factors of Patients with Extramedullary Relapse Multiple Myeloma
    Yue, XiaoYan
    Zheng, GaoFeng
    He, Donghua
    Yang, Yang
    Han, Xiaoyan
    Li, Yi
    Zhao, Yi
    Chen, Qingxiao
    Wu, WenJun
    Huang, He
    Cai, Zhen
    He, Jingsong
    BLOOD, 2022, 140 : 7197 - 7197
12345